Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by GameChangerBeton May 26, 2021 9:22am
127 Views
Post# 33266681

RE:RE:RE:RE:RE:What Happens on May 31

RE:RE:RE:RE:RE:What Happens on May 31As expected, you have missed the point. 
The point that was made, was a simple one.
There may be things wrong with a company, management might be inadequate, etc.
If this is your position, your action to mitigate that concern is to continuously repeat the same, zero value rhetoric about how terrible things are.

The point is a very clear one. With any investment, your seeing the actions of managament, your seeing the performance of the stock, all information is availabale to you.

The stock, Dan, management, rotation out of healthcare, throw in anything else to the list.
There's a diferrence between these things having issues, and the actual issue itself, which is:
You are in this, and any other investment voluntarily.


StockingUp21 wrote:

Ok I will blindly defend company. Nothing is wrong it's everyone else fault. How's this?

 

GameChangerBet wrote:

 

StockingUp21 wrote:

The only hurdle is guy who you just heard from. 

 

Forestview wrote: Actually just heard from Dan.  So, the MC will increase as it absorbs AH.  How the market reacts will drive share price.  Hopefully this is the last hurdle holding this stock down.  

 

 




Do you have any inventory in your vocabulary other than "dilution" "pumper" "Dan this Dan that" ? This is the only basis of your posts in it's totality.

Do you comprehend the stupidity and foolishness of being so negative about an investment or a significant aspect of it to the point where your entire repertoire consists of nothing but negative sentiment but still maintaining your position in that investment.

-Management is terrible
-Nothing but delays
-Nothing but pumperes
-Nothing but dilution
Coclusion: Let me keep my money there. 
Foolishness

Come with some intellect, and articulate that intelligence in a way that's understood. Provide something of substance that can add value.
Or
Take a step back, have a seat, and please, stop talking during the movie, others are trying to pay attention.





<< Previous
Bullboard Posts
Next >>